is an early-stage pharmaceutical company developing new proprietary drugs for diabetes and related disorders. BioKier has identified a therapeutic opportunity and is developing a novel treatment for type 2 diabetes. This treatment will potentially also have effects in metabolic syndrome and obesity.

Read More

John Doe, Senior Manager - Dell Computers

Jerzy “George” Szewczyk, Ph.D

is an inventor of BioKier’s technology and author of BioKier’s patents. He has more than 20 years experience in drug discovery, including working for GlaxoSmithKline and legacy organizations, where he led cross-disciplinary teams in drug discovery efforts. Dr. Szewczyk serves as Chief Executive Officer, Chief Science Officer and Treasurer of BioKier, Inc.

Roger Nolan, Ph.D

has over 25 years of experience in research and drug development in both the CRO and pharmaceutical industries. Dr. Nolan serves as President and Chief Operating Officer of BioKier, Inc.

Read More


Postal Mail:

BioKier, Inc.
PO Box 3855
Chapel Hill, NC 27515


Find out all the latest news about BioKier and our products.

Read more


Learn about the events BioKier is attending and participating in.

Read more


Read about discoveries and trends in diabetes treatments and more.

Read more


Useful links from trusted sources related to diabetes and treatments.

Read more